IGC Pharma, Inc. Quarterly Common Stock, Shares, Issued from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
IGC Pharma, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q1 2010 to Q2 2024.
  • IGC Pharma, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 75.6M shares, a 42.5% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 75.6M +22.6M +42.5% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 66.7M +13.6M +25.6% Mar 31, 2024 10-Q 2024-08-07
Q4 2023 63.7M +10.7M +20.1% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 63.7M +10.6M +20.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 53.1M +1.24M +2.39% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 53.1M +2.02M +3.96% Mar 31, 2023 10-K 2024-06-24
Q4 2022 53.1M +2.02M +3.96% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 53.1M +2.02M +3.95% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 51.8M +3.56M +7.37% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 51.1M +3.23M +6.75% Mar 31, 2022 10-K 2023-07-07
Q4 2021 51.1M +9.75M +23.6% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 51M +9.74M +23.6% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 48.3M +7.09M +17.2% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 47.8M +8.51M +21.6% Mar 31, 2021 10-K 2022-06-23
Q4 2020 41.3M +1.73M +4.38% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 41.3M +1.73M +4.38% Sep 30, 2020 10-Q 2020-11-20
Q2 2020 41.2M +1.68M +4.26% Jun 30, 2020 10-Q 2020-08-19
Q1 2020 39.3M -181K -0.46% Mar 31, 2020 10-K 2021-06-14
Q4 2019 39.6M -15.4K -0.04% Dec 31, 2019 10-Q 2020-02-10
Q3 2019 39.6M +5.32M +15.5% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 39.5M +8.47M +27.3% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 39.5M +8.74M +28.4% Mar 31, 2019 10-K 2020-07-13
Q4 2018 39.6M +10.1M +34.2% Dec 31, 2018 10-Q 2019-02-12
Q3 2018 34.2M +6.24M +22.3% Sep 30, 2018 10-Q 2018-10-16
Q2 2018 31M +4.24M +15.8% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 30.8M +2.49M +8.81% Mar 31, 2018 10-K 2019-06-14
Q4 2017 29.5M -342K -1.15% Dec 31, 2017 10-Q 2018-02-20
Q3 2017 28M +4.05M +16.9% Sep 30, 2017 10-Q 2017-11-17
Q2 2017 26.8M +3.54M +15.2% Jun 30, 2017 10-Q 2017-08-18
Q1 2017 28.3M +5.01M +21.5% Mar 31, 2017 10-K 2018-06-21
Q4 2016 29.8M +12.7M +74.3% Dec 31, 2016 10-Q 2017-02-21
Q3 2016 24M +7.73M +47.7% Sep 30, 2016 10-Q 2016-11-21
Q2 2016 23.3M +8.27M +55.2% Jun 30, 2016 10-Q 2016-08-16
Q1 2016 23.3M +8.5M +57.6% Mar 31, 2016 10-K 2017-07-14
Q4 2015 17.1M +3.6M +26.6% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 16.2M +3.97M +32.4% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 15M +2.5M +20% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 14.8M +5.39M +57.5% Mar 31, 2015 10-K 2016-07-14
Q4 2014 13.5M +5.54M +69.4% Dec 31, 2014 10-Q 2015-02-12
Q3 2014 12.2M +4.77M +63.7% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 12.5M +5.46M +77.6% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 9.37M +2.39M +34.3% Mar 31, 2014 10-K 2015-07-14
Q4 2013 7.98M -52.1M -86.7% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 7.48M -52.6M -87.5% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 7.03M -53M -88.3% Jun 30, 2013 10-Q 2013-08-16
Q1 2013 6.98M +974K +16.2% Mar 31, 2013 10-K 2014-07-15
Q4 2012 60.1M +12.5M +26.2% Dec 31, 2012 10-Q 2013-02-13
Q3 2012 60.1M +44M +273% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 60.1M +44M +273% Jun 30, 2012 10-Q/A 2012-08-21
Q1 2012 6.01M -8.88M -59.7% Mar 31, 2012 10-K/A 2014-07-15
Q4 2011 47.6M Dec 31, 2011 10-Q 2012-02-16
Q3 2011 16.1M Sep 30, 2011 10-Q 2011-11-18
Q2 2011 16.1M Jun 30, 2011 10-Q 2011-08-18
Q1 2011 14.9M +13.6M +1046% Mar 31, 2011 10-K 2012-07-16
Q1 2010 1.3M Mar 31, 2010 10-K 2016-07-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.